Results
|
3901.
|
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm. [electronic resource] by
- Barrio, Santiago
- Gallardo, Miguel
- Arenas, Alicia
- Ayala, Rosa
- Rapado, Inmaculada
- Rueda, Daniel
- Jiménez-Ubieto, Ana
- Albizua, Enriqueta
- Burgaleta, Carmen
- Gilsanz, Florinda
- Martinez-Lopez, Joaquin
Producer: 20130708
In:
British journal of haematology vol. 161
Availability: No items available.
|
|
3902.
|
|
|
3903.
|
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia. [electronic resource] by
- Yee, Karen W L
- Chen, Hsiao-Wei T
- Hedley, David W
- Chow, Sue
- Brandwein, Joseph
- Schuh, Andre C
- Schimmer, Aaron D
- Gupta, Vikas
- Sanfelice, Deborah
- Johnson, Tara
- Le, Lisa W
- Arnott, Jamie
- Bray, Mark R
- Sidor, Carolyn
- Minden, Mark D
Producer: 20171214
In:
Investigational new drugs vol. 34
Availability: No items available.
|
|
3904.
|
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia. [electronic resource] by
- Leonard, Jessica T
- Rowley, Joelle S J
- Eide, Christopher A
- Traer, Elie
- Hayes-Lattin, Brandon
- Loriaux, Marc
- Spurgeon, Stephen E
- Druker, Brian J
- Tyner, Jeffrey W
- Chang, Bill H
Producer: 20171218
In:
Science translational medicine vol. 8
Availability: No items available.
|
|
3905.
|
|
|
3906.
|
|
|
3907.
|
|
|
3908.
|
|
|
3909.
|
|
|
3910.
|
|
|
3911.
|
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3. [electronic resource] by
- Spiekermann, Karsten
- Dirschinger, Ralf J
- Schwab, Ruth
- Bagrintseva, Ksenia
- Faber, Florian
- Buske, Christian
- Schnittger, Susanne
- Kelly, Louise M
- Gilliland, D Gary
- Hiddemann, Wolfgang
Producer: 20030313
In:
Blood vol. 101
Availability: No items available.
|
|
3912.
|
|
|
3913.
|
|
|
3914.
|
|
|
3915.
|
|
|
3916.
|
|
|
3917.
|
|
|
3918.
|
|
|
3919.
|
|
|
3920.
|
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. [electronic resource] by
- Quintás-Cardama, A
- Tong, W
- Manshouri, T
- Vega, F
- Lennon, P A
- Cools, J
- Gilliland, D G
- Lee, F
- Cortes, J
- Kantarjian, H
- Garcia-Manero, G
Producer: 20080626
In:
Leukemia vol. 22
Availability: No items available.
|